Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrating Mechanics and Bioactivity: A Detailed Assessment of Elasticity and Viscoelasticity at Different Scales in 2D Biofunctionalized PEGDA Hydrogels for Targeted Bone Regeneration.
López-Serrano C, Côté-Paradis Y, Habenstein B, Loquet A, Le Coz C, Ruel J, Laroche G, Durrieu MC. López-Serrano C, et al. Among authors: ruel j. ACS Appl Mater Interfaces. 2024 Jul 31;16(30):39165-39180. doi: 10.1021/acsami.4c10755. Epub 2024 Jul 23. ACS Appl Mater Interfaces. 2024. PMID: 39041490 Free PMC article.
FLT3 signaling inhibition abrogates opioid tolerance and hyperalgesia while preserving analgesia.
Jouvenel A, Tassou A, Thouaye M, Ruel J, Antri M, Leyris JP, Giraudin A, Mallié S, Sar C, Diouloufet L, Sonrier C, Daubeuf F, Bertin J, Alves S, Ventéo S, Frossard N, Carroll P, Mechaly I, Rognan D, Sokoloff P, Dallel R, Delmas P, Valmier J, Rivat C. Jouvenel A, et al. Among authors: ruel j. Nat Commun. 2024 Nov 7;15(1):9633. doi: 10.1038/s41467-024-54054-y. Nat Commun. 2024. PMID: 39511220 Free PMC article.
Involvement of Autistic Adults in Recreational Activities.
Préfontaine I, Normand C, Berbari J, Fecteau S, Ruel J, Couture M; ACAA TEAM. Préfontaine I, et al. Among authors: ruel j. J Autism Dev Disord. 2024 Sep 6. doi: 10.1007/s10803-024-06521-0. Online ahead of print. J Autism Dev Disord. 2024. PMID: 39240464
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
144 results